Natera Appoints Solomon Moshkevich as CEO in Leadership Transition
Natera, Inc. announced the immediate appointment of Solomon Moshkevich as Chief Executive Officer and Board Director, succeeding Steve Chapman, who is stepping down to serve as a long-term consultant and board advisor. Moshkevich, who joined Natera in 2011, brings 15 years of extensive company experience across global marketing, product management, commercial operations, business development, and regulatory affairs, having successfully built and led multiple core functional teams during his tenure.
Natera, Inc. (NTRA) announced that Solomon Moshkevich has been appointed Chief Executive Officer and a member of the company’s Board of Directors, effective immediately.
Steve Chapman will step down from the CEO role but will remain a consultant to Natera for an extended period. He will also continue as an advisor to the Board of Directors.
Moshkevich joined Natera in 2011 and has spent 15 years with the company. During his tenure, he has built and led teams across global marketing, product management, medical and scientific affairs, commercial operations, clinical trial operations, international sales and business development, regulatory and quality affairs, and portfolio strategy.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.